Literature DB >> 18042925

New NSCLC staging raises treatment issues.

Caroline McNeil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18042925     DOI： 10.1093/jnci/djm259

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  1 in total

1.  A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer.

Authors:  Georg Holgersson; Stefan Bergström; Johan Harmenberg; Magnus Ringbom; Maria Klockare; Markus Jerling; Simon Ekman; Kristina Lamberg Lundström; Hirsh Koyi; Eva Brandén; Olle Larsson; Michael Bergqvist
Journal:  Med Oncol       Date:  2015-03-21       Impact factor: 3.064
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.